NZYM B Novozymes A/S Class B

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

 

 June 6, 2024

Company announcement No. 20
 

Incentive program for the Executive Leadership Team 2024-2026

In line with previous year, a new long-term incentive program (LTI) for the Executive Leadership Team covering the performance period 2024-2026 has been established. The program complies with the Remuneration Policy for the Executive Management and the Board of Directors of Novonesis, as approved at Novonesis Annual Shareholders’ Meeting on April 30, 2024. The LTI consists of 100% performance shares. The performance measures have 40% weight on compounded annual revenue growth, 20% weight on adjusted EBITDA, 20% weight on adjusted ROIC excluding goodwill, and 20% weight on non-financial sustainability targets.

The value of the program is based on the average trading price for Novonesis B shares on Nasdaq Copenhagen during the first five trading days following annual report publication.

Potential shares will be awarded at the beginning of 2027 subject to achievements relative to the performance targets. The value of the 2024-2026 program is approximately EUR 6.3 million, corresponding to approximately 131,000 shares at target performance (max is 197,000 shares).

Incentive program for the Senior Leadership Team and directors

Also in line with previous years a new incentive program for the Senior Leadership Team and directors covering the period 2024-2026 has been established. The new program is based on the same requirements and targets as the Executive Leadership Team’s LTI. The value of the program is approximately EUR 8 million, corresponding to approximately 166,000 shares at target performance (max is 250,000 shares).

Directors employed under legacy Chr. Hansen employment terms are not part of the program, as they are covered by legacy RSU programs as announced on April 8, 2024 (Stock Exchange announcement no. 12).

Incentive program for selected employees

As in previous years, the Board of Directors has renewed the non-executive annual incentive program, now established for 2024. The aim of the program is for the executive management to be able to award shares to employees as a personal bonus for outstanding efforts or for retention purposes. Given the nature of the program, the recipients of the incentives are not known at this point. Members of the Executive Management cannot be awarded incentives under this program. The program has a three-year performance period as well. The total cost of the program cannot exceed EUR 0.5 million, which at the current valuation corresponds to about 11,000 shares.



Contact information

Tobias Bjorklund





Anders Enevoldsen



Disa Tuominen





Attachment



EN
06/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments. Per September 6, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,289,066 shares, corresponding to 4.97% (previously 5.00%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial ins...

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments. Per September 2, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,377,683 shares, corresponding to 4.99% (previously 5.12%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch